BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Fluoxetine
,
rs6983267
,
FOXP1
,
cell-cell adhesion
,
HIV infection
,
Stem cell
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
pro-%203
Summary
General Info
Curated Studies
Most Correlated Studies
There were no matches for pro-%203
Explore Curated Studies Results
Literature
Most Relevant Literature
Identification of C/EBPα as a novel target of the HPV8 E6 protein regulating miR-203 in human kerati…
High serum fibroblast growth factor 21 levels were related to the prognosis and ventricular remodeli…
The effectiveness of cervical rehabilitation interventions for pain in adults with myogenic temporom…
Association between e-cigarette use and asthma: a systematic review and meta-analysis.
Pharmacologic Interventions to Minimize Fluid Absorption at the Time of Hysteroscopy: A Systematic R…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Proof-of-Concept Study of Topical AC-203 in Patients With Bullous Pemphigoid
A Safety Study of Intravenous Pro-Netupitant and Palonosetron Combination for the Prevention of Naus…
Double-blind, Randomized, Placebo-controlled, Prospective Phase III Study Evaluating Efficacy and Sa…
Muscular Resistance Test in the Elastic Tube: Reliability and Training of the Proposed Method
The In4M Study: Integrating 4 Measures to Assess Physical Function in Cancer Patients
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ